D2V Clinical is a full-service global CRO offering world-class clinical development insight and end-to-end capabilities combined with a robust PI network and hospital-specific patient prevalence data access to expedite enrollment. With more than 20 years of leadership in clinical research and investor value creation, we bring the depth of knowledge required to value your asset, connect your studies to the right patient populations and sites, and conduct an efficient and seamless study – all with speed and quality. Let our expertise and relationship-driven approach give you the confidence to expedite drug signal detection and advance your program.
Meet D2V Clinical
At D2V Clinical, our mission is to accelerate your journey from vision to victory—turning innovative ideas into life-changing therapies. Our executive team, with decades of experience spanning Contract Research Organizations,the FDA, and leading pharmaceutical companies, brings unparalleled expertise to every project. We’re not just a CRO; we’re your strategic partner, delivering customized solutions with precision, agility, and a relentless focus on your success.

- 20+ years in global drug development
- FDA and global biopharmaceutical development roles
- 80+ FDA PK/PD early-phase oncology reviews
- Designed 65+ early-phase oncology and hematology studies
- 100+ experiences including Ibrutinib, Brexpiprazole, and Durvalumab
- Access to
- 300 GCP sites/hospitals
- hospital prevalence data for 400M patients and 1M+ PIs
Decades of experience combined with exceptional poise and a vast network of sites.

Expert team
World-class clinical development insight delivered with a hands-on approach
- 20 years of remarkable leadership in studies across the world including roles in pharma, biotech, academia and senior FDA review.
- Advise biopharmaceutical sponsors on the most direct routes to global approvals.
- Flexible, relationship-driven approach offering less bureaucracy, interaction with our senior team, interpersonal communication, and a passionate investment in our clients’ success.

End-to-end capabilities
From early strategy through regulatory submission
- Early planning to avoid issues and delays.
- Removing barriers across the development continuum.
- Strategic partnerships with leading medical centers and sites.
- Streamlined digital innovation strategies including online patient reporting, remote monitoring and digital patient visits.

Connecting bridges
Tap into a rich research landscape and vast patient population
- Connections that include KOL and site networks, top clinical experts, leading medical centers, PIs, regulatory authorities and patient networks.
- Dual track project management - sponsor local and enrollment region local to ensure seamless international communication.
across border disease research
We offer global capabilities and comprehensive solutions, resting on a foundation of clinical resources across the world. Our wide global reach allows biopharmaceutical sponsors to find the right sites and right patients, all with speed, efficiency and quality.
